@TonzaWell said ! 100% concur
Nowadays, not all journalists are specialists in their field of writing/reporting rightly or wrongly but quite sadly. Coincidence or otherwise, only journo Tom or Mary will know.
However, science don’t lie. If AXE continues to deliver the science, money will follow eventually. As recent as 27 May, an Aussie biotech startup in immuno-oncology for potential cancer cure drugs was “selectively“ reported by Tom. As a result of his misleading reporting, it’s SP had plunged nearly 40% within the first 5 minutes of trading with 260 million shares transacted versus a daily average of 30 million! Tom did his 2nd article as soon as it’s SP had recovered 10%... Thanks goodness, it’s SP has almost bounced back as of closing today! It may be a painful roller coaster journey especially for those new investors who entered at the ATH price levels. However, if we have done the due research/diligence, and believe in the management and their scientists, it can be a rewarding journey. Tom Mary may do his her 3rd misleading article, but it will bring even more new investors onboard after their research and DD.
Wealth is transferred to those who are patient from the impatient
Last but not least, after coming across the AFR article, I have just become a newbie investor in AXE today
Fingers crossed.
(20min delay)